PMID- 15904473 OWN - NLM STAT- MEDLINE DCOM- 20050707 LR - 20181201 IS - 1083-4389 (Print) IS - 1083-4389 (Linking) VI - 10 IP - 3 DP - 2005 Jun TI - Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication. PG - 157-71 AB - OBJECTIVE: To systematically review the Helicobacter pylori eradication efficacy with ranitidine bismuth citrate (RBC) and two antibiotics, and to conduct a meta-analysis of randomized clinical trials comparing the efficacy of proton pump inhibitor (PPI) vs. RBC with two antibiotics for 1 week. SELECTION OF STUDIES: Studies evaluating RBC plus two antibiotics were considered. For the meta-analysis, randomized controlled trials comparing PPI vs. RBC plus two antibiotics for 1 week were included. SEARCH STRATEGY: Electronic and manual bibliographical searches. Assessment of study quality and data extraction: Independently done by two reviewers. DATA SYNTHESIS: 'Intention-to-treat' eradication rate. Meta-analysis was performed, combining the odds ratios (OR) of the individual studies. Subanalysis: Depending on the type of antibiotics and the quality of the studies. RESULTS: Mean H. pylori eradication with 7-day RBC-clarithromycin-amoxicillin, RBC-clarithromycin-nitroimidazole, and RBC-amoxicillin-nitroimidazole was 83%, 86%, and 71%, respectively. The meta-analysis showed comparable efficacy with RBC and PPI when they were combined with clarithromycin and amoxicillin (OR = 1.11; 95% CI = 0.88-1.40), or with amoxicillin and metronidazole (OR = 0.92; 95%CI = 0.60-1.41). However, when comparing PPI vs. RBC plus clarithromycin and a nitroimidazole, higher cure rates with RBC than with PPI were demonstrated (OR = 1.65; 95% CI = 1.15-2.37). CONCLUSION: The efficacy of RBC and PPI-based triple regimens were comparable when using the clarithromycin-amoxicillin or the amoxicillin-metronidazole combination. However, RBC seems to have a higher efficacy than PPI when clarithromycin and a nitroimidazole are the antibiotics prescribed. Therefore, if one prefers to use the clarithromycin-nitroimidazole regimen, RBC should be used instead of a PPI. FAU - Gisbert, Javier P AU - Gisbert JP AD - Department of Gastroenterology, University Hospital of La Princesa, Madrid, Spain. gisbert@meditex.es FAU - Gonzalez, Leticia AU - Gonzalez L FAU - Calvet, Xavier AU - Calvet X LA - eng PT - Comparative Study PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PT - Review PT - Systematic Review PL - England TA - Helicobacter JT - Helicobacter JID - 9605411 RN - 0 (Anti-Bacterial Agents) RN - 0 (Anti-Ulcer Agents) RN - 0 (Nitroimidazoles) RN - 0 (Proton Pump Inhibitors) RN - 7AJ51I17KG (ranitidine bismuth citrate) RN - 804826J2HU (Amoxicillin) RN - 884KT10YB7 (Ranitidine) RN - H1250JIK0A (Clarithromycin) RN - U015TT5I8H (Bismuth) SB - IM MH - Amoxicillin/administration & dosage/therapeutic use MH - Anti-Bacterial Agents/administration & dosage/*therapeutic use MH - Anti-Ulcer Agents/administration & dosage/*therapeutic use MH - Bismuth/administration & dosage/*therapeutic use MH - Clarithromycin/administration & dosage/therapeutic use MH - Drug Therapy, Combination MH - Helicobacter Infections/*drug therapy/microbiology MH - Helicobacter pylori/*drug effects MH - Humans MH - Nitroimidazoles/administration & dosage/therapeutic use MH - *Proton Pump Inhibitors MH - Randomized Controlled Trials as Topic MH - Ranitidine/administration & dosage/*analogs & derivatives/*therapeutic use RF - 117 EDAT- 2005/05/21 09:00 MHDA- 2005/07/08 09:00 CRDT- 2005/05/21 09:00 PHST- 2005/05/21 09:00 [pubmed] PHST- 2005/07/08 09:00 [medline] PHST- 2005/05/21 09:00 [entrez] AID - HEL307 [pii] AID - 10.1111/j.1523-5378.2005.00307.x [doi] PST - ppublish SO - Helicobacter. 2005 Jun;10(3):157-71. doi: 10.1111/j.1523-5378.2005.00307.x.